ABBOTT INDIA Financial Statement Analysis
|
||
|
The Revenues of ABBOTT INDIA have increased by 8.86% YoY .
The Earnings Per Share (EPS) of ABBOTT INDIA has increased by 26.52 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ABBOTT INDIA Last 5 Annual Financial Results
[BOM: 500488|NSE : ABBOTINDIA]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr | ₹4,093 Cr | ₹367,860 Cr |
| Expenses | ₹4,143 Cr | ₹3,832 Cr | ₹3,391 Cr | ₹3,337 Cr | ₹307,456 Cr |
| Operating Profit (Excl OI) | ₹1,205 Cr | ₹1,082 Cr | ₹919 Cr | ₹756 Cr | ₹60,405 Cr |
| Other Income | ₹154 Cr | ₹83 Cr | ₹83 Cr | ₹115 Cr | ₹11,398 Cr |
| Interest | ₹16 Cr | ₹19 Cr | ₹18 Cr | ₹8.53 Cr | ₹225 Cr |
| Depreciation | ₹70 Cr | ₹66 Cr | ₹58 Cr | ₹60 Cr | ₹1,692 Cr |
| Profit Before Tax | ₹1,274 Cr | ₹1,080 Cr | ₹926 Cr | ₹803 Cr | ₹69,885 Cr |
| Profit After Tax | ₹949 Cr | ₹799 Cr | ₹691 Cr | ₹593 Cr | ₹45,033 Cr |
| Earnings Per Share (Rs) | ₹565.28 | ₹446.78 | ₹375.86 | ₹325.03 | ₹279.03 |
| PAT Margin (%) | 19.88 | 17.29 | 15.89 | 15.45 | 14.49 |
| ROE(%) | 35.31 | 32.07 | 29.95 | 27.89 | 27.09 |
| ROCE(%) | 47.34 | 42.93 | 40.53 | 37.52 | 36.54 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 58,903.6 Cr |
| Revenue (TTM) | : | ₹ 6,243.2 Cr |
| Net Profit(TTM) | : | ₹ 1,334.5 Cr |
| EPS (TTM) | : | ₹ 629.5 |
| P/E (TTM) | : | 44.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ABBOTT INDIA | 6.3% | -6.1% | -6.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -4.6% | 20.7% |
| CIPLA | -2.9% | -3.9% | 1.1% |
| DR REDDYS LABORATORIES | 0.9% | -10.4% | 0.1% |
| ZYDUS LIFESCIENCES | 0.9% | -0.3% | 27.9% |
| DIVIS LABORATORIES | 9.8% | 4.5% | 64.7% |
| MANKIND PHARMA | 1.9% | -13.7% | 24% |
| TORRENT PHARMACEUTICALS | -4.4% | -6.3% | 17.5% |
| LUPIN | 5.1% | -2.9% | 34.2% |
ABBOTT INDIA Revenues
[BOM: 500488|NSE : ABBOTINDIA]
| Y-o-Y | 8.86 % |
| 5 Yr CAGR | -65.28 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹5,349 Cr | 8.86 | |
| Mar2023 | ₹4,913 Cr | 14.00 | |
| Mar2022 | ₹4,310 Cr | 5.30 | |
| Mar2021 | ₹4,093 Cr | -98.89 | |
| Mar2020 | ₹367,860 Cr | - | |
ABBOTT INDIA Operating Profit
[BOM: 500488|NSE : ABBOTINDIA]
| Y-o-Y | 11.46 % |
| 5 Yr CAGR | -62.41 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,205 Cr | 11.46 | |
| Mar2023 | ₹1,082 Cr | 17.71 | |
| Mar2022 | ₹919 Cr | 21.52 | |
| Mar2021 | ₹756 Cr | -98.75 | |
| Mar2020 | ₹60,405 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.41 % |
| 5 Yr CAGR | 8.24 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 22.54% | 2.41 | |
| Mar2023 | 22.01% | 3.24 | |
| Mar2022 | 21.32% | 15.43 | |
| Mar2021 | 18.47% | 12.48 | |
| Mar2020 | 16.42% | - | |
ABBOTT INDIA Profit After Tax
[BOM: 500488|NSE : ABBOTINDIA]
| Y-o-Y | 18.87 % |
| 5 Yr CAGR | -61.90 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹949 Cr | 18.87 | |
| Mar2023 | ₹799 Cr | 15.64 | |
| Mar2022 | ₹691 Cr | 16.49 | |
| Mar2021 | ₹593 Cr | -98.68 | |
| Mar2020 | ₹45,033 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 14.98 % |
| 5 Yr CAGR | 8.23 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 19.88 % | 14.98 | |
| Mar2023 | 17.29 % | 8.81 | |
| Mar2022 | 15.89 % | 2.85 | |
| Mar2021 | 15.45 % | 6.63 | |
| Mar2020 | 14.49 % | - | |
ABBOTT INDIA Earnings Per Share (EPS)
[BOM: 500488|NSE : ABBOTINDIA]
| Y-o-Y | 26.52 % |
| 5 Yr CAGR | 19.30 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹565 | 26.52 | |
| Mar2023 | ₹447 | 18.87 | |
| Mar2022 | ₹376 | 15.64 | |
| Mar2021 | ₹325 | 16.49 | |
| Mar2020 | ₹279 | - | |
ABBOTT INDIA Return on Capital Employed (ROCE)
[BOM: 500488|NSE : ABBOTINDIA]
| Y-o-Y | 10.27 % |
| 5 Yr CAGR | 6.69 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 47.34% | 10.27 | |
| Mar2023 | 42.93% | 5.92 | |
| Mar2022 | 40.53% | 8.02 | |
| Mar2021 | 37.52% | 2.68 | |
| Mar2020 | 36.54% | - | |
ABBOTT INDIA Share Price vs Sensex
| Current Share Price | : | ₹27,784.7 |
| Current MarketCap | : | ₹ 58,903.6 Cr |
| Updated EOD on | : | Feb 05,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 6.3% |
-6.1% |
-6.8% |
| SENSEX | 2% |
0.1% |
8.6% |
ABBOTT INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.5% | -5.3% | 27.5% |
| S&P BSE MIDSMALLCAP | 2.7% | -7.4% | 10.8% |
| S&P BSE 400 MIDSMALLCAP | 2.7% | -6.5% | 10.3% |
| S&P BSE 150 MIDCAP | 2.4% | -5.4% | 12.6% |
| S&P BSE MID CAP | 2.4% | -6% | 11.4% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY HEALTHCARE | 2.9% | -5.3% | 24.3% |
| NIFTY MID SMALL400 | 2.8% | -6.5% | 9.8% |
| NIFTY500 MULTICAP 50:25:25 | 2.5% | -4% | 9.3% |
| NIFTY MIDCAP150 | 2.5% | -5.1% | 11.9% |
| NIFTY 500 | 2.3% | -2.5% | 9.4% |
You may also like the below Video Courses
FAQ about ABBOTT INDIA Financials
How the annual revenues of ABBOTT INDIA have changed ?
The Revenues of ABBOTT INDIA have increased by 8.86% YoY .
How the Earnings per Share (EPS) of ABBOTT INDIA have changed?
The Earnings Per Share (EPS) of ABBOTT INDIA has increased by 26.52 % YoY .
Check out Intrinsic Value of Peers of ABBOTT INDIA
Compare Stock Analytics of Peers of ABBOTT INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
